|
Volumn 132, Issue 3 I, 1998, Pages 543-546
|
A pilot study of combination therapy with indinavir, stavudine (d4T), and didanosine (ddI) in children infected with the human immunodeficiency virus
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CD4 ANTIGEN;
DIDANOSINE;
INDINAVIR;
STAVUDINE;
VIRUS RNA;
ANTIVIRAL ACTIVITY;
ARTICLE;
CHILD;
CHILDHOOD DISEASE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG HALF LIFE;
FEMALE;
GASTROINTESTINAL TOXICITY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
JAUNDICE;
LYMPHOCYTE COUNT;
MALE;
NEPHROTOXICITY;
ORAL DRUG ADMINISTRATION;
PARESTHESIA;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
|
EID: 0031894889
PISSN: 00223476
EISSN: None
Source Type: Journal
DOI: 10.1016/S0022-3476(98)70039-3 Document Type: Article |
Times cited : (50)
|
References (8)
|